Cargando…
Empagliflozin Administration Can Decrease the Dose of Loop Diuretics and Prevent the Exacerbation of Renal Tubular Injury in Patients With Compensated Heart Failure Complicated by Diabetes
Background: Whether the dose of loop diuretics can be decreased by administration of a sodium-glucose cotransporter 2 (SGLT2) inhibitor in diabetic outpatients with compensated heart failure (HF) is unclear. Methods and Results: This study prospectively enrolled 60 diabetic outpatients with compensa...
Autores principales: | Shirakabe, Akihiro, Matsushita, Masato, Kiuchi, Kazutaka, Okazaki, Hirotake, Inami, Toru, Takayasu, Tsutomu, Asano, Miwako, Nomura, Akiko, Kobayashi, Nobuaki, Okajima, Fumitaka, Miyauchi, Yasushi, Asai, Kuniya, Shimizu, Wataru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Circulation Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932847/ https://www.ncbi.nlm.nih.gov/pubmed/33693182 http://dx.doi.org/10.1253/circrep.CR-20-0041 |
Ejemplares similares
-
Effect of Empagliflozin in Preventing Progression of Renal Dysfunction in Diabetic Patients With Compensated Heart Failure ― Reply ―
por: Shirakabe, Akihiro, et al.
Publicado: (2021) -
Plasma Xanthine Oxidoreductase (XOR) Activity in Cardiovascular Disease Outpatients
por: Matsushita, Masato, et al.
Publicado: (2020) -
Clinical Significance of Low-Triiodothyronine Syndrome in Patients Requiring Non-Surgical Intensive Care ― Triiodothyronine Is a Comprehensive Prognostic Marker for Critical Patients With Cardiovascular Disease ―
por: Shigihara, Shota, et al.
Publicado: (2021) -
Prognostic Value of Both Plasma Volume Status and Nutritional Status in Patients With Severely Decompensated Acute Heart Failure
por: Shirakabe, Akihiro, et al.
Publicado: (2019) -
Plasma xanthine oxidoreductase activity in patients with decompensated acute heart failure requiring intensive care
por: Okazaki, Hirotake, et al.
Publicado: (2019)